Nymak Pharma Private Limited, a active private limited company, was established on 23 September 2014 in Mundra, Gujarat, India. Engaging in drug formulation & development within the support service to organizations sector, it holds CIN: U33110GJ2014PTC080874. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.65 Cr and a paid-up capital of ₹5.00 M.
Formerly known as Nymak Pharma Limited. It upholds a compliant status. Its leadership includes Ranjit Sundersing Advani (Director), Deepa Haresh Advani (Director), Haresh Ranjit Advani (Director). Past directors included Bharti Vinod Nankani, Vinod Tarachand Nankani. It holds ₹2.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 22, Port Bizz Phase No 3, First Floor, Sr No 343, 393/1, 394, 395/1, 395/2, 401/P1, 401/2, 402, Sh 06, Kandla Mundra Highway Bhadresar, Mundra, Gujarat, 370410.
U33110GJ2014PTC080874
080874
23 September 2014
₹2.65 Cr
₹5.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nymak Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjit Sundersing Advani | Director | 23 Sep 2014 | Current |
| Deepa Haresh Advani | Director | 23 Sep 2014 | Current |
| Haresh Ranjit Advani | Director | 23 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Oct 2021 | Past |
| Pramod Abcsdd | Director | 17 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nymak Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 31.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Nymak Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹25,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2024 | Uco Bank | ₹6.00 M | Open |
| 25 Sep 2024 | Uco Bank | ₹1.90 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nymak Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nymak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nymak Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nymak Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Uco Bank amounted to Rs. 0.60 Cr with Charge ID 100982683 was registered on 25 Sep 2024. was documented.
Progress on A charge with Uco Bank amounted to Rs. 1.90 Cr with Charge ID 100980326 was registered on 25 Sep 2024. was documented.
The activity Nymak Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity Ranjit Sundersing Advani was appointed as a Director was appointed as a Director on 23 Sep 2014 & has been associated with this company since 11 years 2 months . was completed.
The activity Deepa Haresh Advani was appointed as a Director was appointed as a Director on 23 Sep 2014 & has been associated with this company since 11 years 2 months . was completed.
The CIN of Nymak Pharma Private Limited is U33110GJ2014PTC080874.
Nymak Pharma Private Limited is headquartered at Plot No 22, Port Bizz Phase No 3, First Floor, Sr No 343, 393/1, 394, 395/1, 395/2, 401/P1, 401/2, 402, Sh 06, Kandla Mundra Highway Bhadresar, Mundra, Gujarat, 370410.
Nymak Pharma Private Limited was incorporated on 23 September 2014.
The current directors of Nymak Pharma Private Limited are
The primary industry of Nymak Pharma Private Limited is Support Service To Organizations.
Nymak Pharma Private Limited is unlisted.
The authorized capital of Nymak Pharma Private Limited is ₹2.65 Cr, and the paid-up capital is ₹5.00 M.
The compliance status of Nymak Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX